Who
Carl Sailer
Director
Company insider
Files Form 4 as: Director, Acurx Pharmaceuticals.
In numbers
- Trades disclosed
- 14
- Buys
- 4
- Sells
- 0
- Bought
- $200K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 29 Jun 2021
- Last trade
- 20 Apr 2026
- Last filed
- 22 Apr 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 20 Apr 2026filed 22 Apr 2026 | ACXP Acurx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,150 at $0.00 | filing |
| 20 Apr 2026filed 22 Apr 2026 | ACXP Acurx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,150 at $0.00 | filing |
| 6 Jan 2025filed 8 Jan 2025 | ACXP Acurx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code P | —24,631 at $0.00 | filing |
| 6 Jan 2025filed 8 Jan 2025 | ACXP Acurx PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $25K24,631 at $1.02 | filing |
| 17 Jun 2024filed 18 Jun 2024 | ACXP Acurx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,000 at $0.00 | filing |
| 19 Jan 2024filed 22 Jan 2024 | ACXP Acurx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —19,737 at $0.00 | filing |
| 19 Jan 2024filed 22 Jan 2024 | ACXP Acurx PharmaceuticalsBiotechnology | SEC FORM 4 Code M | $70K19,737 at $3.55 | filing |
| 15 Jun 2023filed 16 Jun 2023 | ACXP Acurx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 27 Jul 2022filed 29 Jul 2022 | ACXP Acurx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code P | —19,737 at $0.00 | filing |
| 27 Jul 2022filed 29 Jul 2022 | ACXP Acurx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code P | —19,737 at $0.00 | filing |
| 27 Jul 2022filed 29 Jul 2022 | ACXP Acurx PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $75K19,737 at $3.80 | filing |
| 23 Nov 2021filed 24 Nov 2021 | ACXP Acurx PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $25K5,161 at $4.84 | filing |
| 1 Jul 2021filed 6 Jul 2021 | ACXP Acurx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 29 Jun 2021filed 10 Sep 2021 | ACXP Acurx PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $75K12,500 at $6.00 | filing |
News
Acurx Pharmaceuticals (NASDAQ:ACXP) Shares Climb 0.9% – Should You Buy?ACXP · dailypolitical.com · 22 Oct 2026
0 headlines in the last 90 days name Carl Sailer; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.